Abstract
The enzyme steroid sulfatase (STS) activity is high in breast tumors and elevated levels of STS mRNA expression have been associated with a poor prognosis. Potent STS irreversible inhibitors have been developed, paving the way to use this new type of therapy for breast cancer. Synthetic small molecules belonging to a focused library of inhibitors of tumor cell growth already obtained and new molecules planned to be reversible inhibitors of STS were docked into STS using the program AutoDock 4. To guide the docking process of the select ligands through the lattice volume that divides the receptor’s area of interest, a full set of grid maps was built using the program AutoGrid. Some of the new designed small molecules showed calculated binding affinity for STS presenting ΔG values in a range of -11.15 to -13.07 kcal.mol− 1. The synthesis of the most promising STS inhibitors, based on these results, is in progress.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Castanheiro, R., Pinto, M., Silva, A., et al.: Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Bioorg. Med. Chem. 15, 6080–6088 (2007)
Hejaz, H., Woo, L., Purohit, A., et al.: Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase. Bioorg. Med. Chem. 12, 2759–2772 (2004)
Hernandez-G, F., Higashiyama, T., Pangborn, W., et al.: Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association. J. Biol. Chem. 278, 22989–22997 (2003)
Morris, G., Goodsell, D., Halliday, R., et al.: Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function. J. Comput. Chem. 19, 1639–1662 (1998)
Morris, G., Huey, R., Lindstrom, W., et al.: AutoDock 4 and AutoDock tools 4: automated docking with selective receptor flexibility. J. Comput. Chem. 00, 1–7 (2009)
Nussbaumer, P., Billich, A.: Steroid Sulfatase Inhibitors. Med. Res. Rev. 24, 529–576 (2004)
Pedro, M., Cerqueira, F., Sousa, E., et al.: Xanthones as Inhibitors of Growth of Human Cancer Cell Lines and Their Effects on the Proliferation of Human Lymphocytes In Vitro. Bioorg. Med. Chem. 10, 3725–3730 (2002)
Reed, M., Purohit, A., Woo, L., et al.: Steroid sulfatase: molecular biology, regulation, and inhibition. Endocrine Rev. 26, 171–202 (2005)
Reich, S., Fuhry, M., Nguyen, D., et al.: Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using interactive protein crystal structure analysis. J. Med. Chem. 35, 847–858 (1992)
Sousa, E., Paiva, A., Nazareth, N., et al.: Bromoalkoxyxanthones as promising antitumor agents: Synthesis, crystal structure and effect on human tumor cell lines. Eur. J. Med. Chem. 44, 3830–3835 (2009)
Sousa, E., Silva, A., Pinto, M., et al.: Isomeric Kielcorins and Dihydroxyxanthones: Synthesis, Structure Elucidation, and Inhibitory Activities of Growth of Human Cancer Cell Lines and on the Proliferation of Human Lymphocytes In Vitro. Helv. Chim. Acta. 85, 2862–2876 (2002)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Costa, E.V., Sousa, M.E., Rocha, J., Montanari, C.A., Pinto, M.M. (2010). Structure Based Design of Potential Inhibitors of Steroid Sulfatase. In: Rocha, M.P., Riverola, F.F., Shatkay, H., Corchado, J.M. (eds) Advances in Bioinformatics. Advances in Intelligent and Soft Computing, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13214-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-13214-8_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13213-1
Online ISBN: 978-3-642-13214-8
eBook Packages: EngineeringEngineering (R0)